Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Treasury Shares (2025)

Neuphoria Therapeutics (NEUP) has disclosed Treasury Shares for 1 consecutive years, with $33915.0 as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares changed N/A to $33915.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $33915.0, a N/A change, with the full-year FY2025 number at $33915.0, changed N/A from a year prior.
  • Treasury Shares was $33915.0 for Q3 2025 at Neuphoria Therapeutics, roughly flat from $33915.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $33915.0 in Q2 2025 to a low of $33915.0 in Q2 2025.